Statistical contributions to phase Ii trials in cancer: interpretation, analysis and design
Lee, Y.J.; Wesley, R.A.
Seminars in Oncology 8(4): 403-416
1981
ISSN/ISBN: 0093-7754 PMID: 7323812 Document Number: 178753
Document emailed within 1 workday
Related Documents
Neidert, G.L. 1982: Design and interpretation of clinical trials of long-acting analgesics PharmacoTherapy 2(5): 285-286Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Taylor, D. 2009: Issues in the design, analysis and interpretation of condom functionality studies Contraception 80(3): 237-244
George, A.; Rodríguez, D.C.; Rasanathan, K.; Brandes, N.; Bennett, S. 2015: ICCM policy analysis: strategic contributions to understanding its character, design and scale up in sub-Saharan Africa Health Policy and Planning 30(Suppl 2): Ii3
Antczak-Bouckoms, A.; Chalmers, T.C. 1988: The importance of design and analysis in clinical trials Journal of Oral Implantology 14(1): 36-42
Gaines Das, R.E. 2002: Statistical considerations in the design and analysis of parallel line assays Developments in Biologicals 107: 35-45
Warner, P. 2005: Concerns regarding design, analysis, and interpretation of the morrison study on hormonal contraceptive use and acquisition of cervical infections Sexually Transmitted Diseases 32(10): 644; Author Reply 645
Sylvester, R.; Collette, L. 1999: Statistical considerations of chemoprevention clinical trials in prostate cancer European Urology 35(5-6): 519-522
Sippo, A.C.; Belyavin, A.J. 1991: Determining aircrew helmet size design requirements using statistical analysis of anthropometric data Aviation Space and Environmental Medicine 62(1): 67-74
O'Brien, F.B.; Stewart, W.C.; Sturtevant, F.M. 1983: Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis Contraception 27(2): 111-122
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Shatney, C.H. 1988: Design and conduct of clinical trials in systemic sepsis. Critical analysis of VA Cooperative Study No. 209 Progress in Clinical and Biological Research 264: 71-80
Robinson, M.R.; Smith, P.H.; Macaluso, M.P.; Sylvester, R.; de Voogt, H. 1985: The EORTC Phase IIi trials in prostatic cancer Progress in Clinical and Biological Research 185a: 243-249
Veldhuyzen van Zanten, S.J.; Cleary, C.; Talley, N.J.; Peterson, T.C.; Nyrén, O.; Bradley, L.A.; Verlinden, M.; Tytgat, G.N. 1996: Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials American Journal of Gastroenterology 91(4): 660-673
Li, Y.-s. 2010: To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke Zhonghua Nei Ke Za Zhi 49(9): 733-734
Hou, M-Mo.; Liu, X.; Wheler, J.; Naing, A.; Hong, D.; Bodurka, D.; Schmeler, K.; Tsimberidou, A.; Janku, F.; Zinner, R.; Piha-Paul, S.; Hu, C-Yuan.; Lu, K.; Kurzrock, R.; Fu, S. 2014: Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program Anticancer Research 34(5): 2349-2355
Becouarn, Y.; Rougier, P. 1998: Clinical efficacy of oxaliplatin monotherapy: phase Ii trials in advanced colorectal cancer Seminars in Oncology 25(2 Suppl 5: 23-31